novo nordisk goodrx - Search News

Order byBest matchMost fresh

News

Novo Nordisk Adds Ozempic to Direct-to-Consumer Offerings

· 22h · on MSN

Novo Nordisk Adds Ozempic to Direct-to-Consumer Offerings, at $499 Per Month. Why GoodRx Stock Spikes.

Shares of GoodRx were spiking 35% on Monday. The announcement followed news from Novo Nordisk that the Food and Drug Administration had approved Wegovy for treatment of a serious form of liver disease. Shares of the Danish drugmaker were rising 4.9% in U.S. trading.

Continue reading

· 20h · on MSN

Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers

The Pharma Letter · 4h

GoodRx and Novo Nordisk unveil $499 monthly offer for Ozempic and Wegovy

1hon MSN

Novo Nordisk slashes price of weight loss drugs

Novo Nordisk is teaming up with GoodRx to offer Wegovey and Ozempic for a flat price of $499 a month. Top Air Force general ...

Patients can now get Ozempic for half price if they can pay cash

Novo Nordisk announced Monday that U.S. patients can now get a month's supply of Ozempic, the blockbuster diabetes drug, for ...

19h

GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning?

GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing. Click ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results